DR ZEESHAN BADAR , DR SHEIKH TAHIR SIDDIQUE , DR ZIAUDDIN AHMED , DR ABDUL SAMAD SHAIKH , DR ABDUL GHAFFAR SHAIKH , DR FARYAL AZHAR 2025. EFFICACY AND SAFETY OF RITUXIMAB PLUS DOSE ADJUSTED ETOPOSIDE, PREDNISONE, VINCRISTINE, CYCLOPHOSPHAMIDE AND DOXORUBICIN (R-DA-EPOCH) REGIMEN IN HIGH GRADE DIFFUSE LARGE B- CELL LYMPHOMA PATIENTS (HG-DLBCL). TPM – Testing, Psychometrics, Methodology in Applied Psychology. 32, S8 (2025): Posted 05 November (Nov. 2025), 2910–2915.